We sat down with Glynis Ablon, MD, FAAD to learn about her research on nutraceuticals for hair growth in midlife.
Roughly 40% of women over 60 will experience female pattern hair loss, or androgenetic alopecia. However, new research from the University of California, Los Angeles, suggests nutraceuticals may be the key to hair growth in menopausal women.
Although there are several Food and Drug Administration (FDA)-approved drugs for male and female pattern hair loss, many women prefer more natural medications. The new study suggests that a nutraceutical supplement with nutrient-derived bioactive compounds may promote hair growth in perimenopausal, menopausal, and postmenopausal women.
Hear the perspective of lead author Glynis Ablon of the Ablon Skin Institute and Research Center in California, in the video above.
References
FDA adds boxed warning to fezolinetant for rare serious liver injury
Published: December 17th 2024 | Updated: December 17th 2024The FDA has added a boxed warning for fezolinetant (VEOZAH; Astellas), highlighting the rare occurrence of serious liver injury in patients taking the menopause treatment.
Read More
S3E20: Brooke Faught, NP on sexual health, trauma-informed care, and the perks of meeting in-person
December 3rd 2021In this episode of Pap Talk, we took you with us to the North American Menopause Society's recent Annual Meeting. Sexual health specialist Michael Krychman, MD, sat down with Brooke Faught, NP, to learn more about her work at the Women's Institute for Sexual Health, her role on the NAMS Planning Committee, and her tips for talking trauma with patients.
Listen
Shared genetics found between anti-Müllerian hormone and age at menopause
December 4th 2024In a recent study, an inverse relationship was discovered between anti-Müllerian hormone levels and early menopause, highlighting the need to develop interventions for fertility preservation based on genetics.
Read More